Trial intelligence / Profile preview

Desflurane on Postoperative Sleep Quality in Breast Surgery

NCT04805775Completed

Sponsor
Zhongnan Hospital of Wuhan University
Start
Oct 2021
Primary completion
Sep 2022
Modality
Allosteric Modulators
Countries
1
01

Overview

Randomised trial of desflurane in breast neoplasm (2 arms), sponsored by Zhongnan Hospital of Wuhan University. Primary endpoint: Pittsburgh Sleep Quality Index. Started Oct 2021; status: completed.

02

Drugs

desflurane
03

Conditions

breast neoplasm

Beyond the preview

Go deeper on NCT04805775.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04805775.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call